| Cardiovascular Risk Management |
1 |
1 |
| Heart Failure (HF) |
0 |
1 |
| Biomarker |
0 |
0.72 |
| Heart |
0 |
0.41 |
| Myocardial Infarction (MI) |
0 |
0.41 |
| Statistics |
0 |
0.36 |
| Deep Venous Thrombosis |
0 |
0.24 |
| Pulmonary Embolism |
0 |
0.24 |
| B-Type Natriuretic Peptide |
0 |
0.23 |
| Cardiovascular disease |
0 |
0.23 |
| Blood |
0 |
0.18 |
| Troponin |
0 |
0.14 |
| Muscle |
0 |
0.09 |
| Stress |
0 |
0.09 |
| Cerebrovascular Accident |
0 |
0.08 |
| Genomic Medicine |
0 |
0.08 |
| Revenue and Practice Management |
0 |
0.08 |
| Social Determinants of Health |
0 |
0.08 |
| Toxicology |
0 |
0.08 |